Advertisement

Topics

First Survival Results With Immunotherapy, TNBC

08:00 EDT 3 Apr 2017 | Medscape

The immunotherapy atezolizumab produces responses in a small percentage of triple-negative breast cancer (TNBC) but with a long duration of response.
Medscape Medical News

Original Article: First Survival Results With Immunotherapy, TNBC

NEXT ARTICLE

More From BioPortfolio on "First Survival Results With Immunotherapy, TNBC"

Quick Search
Advertisement
 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...